The Protective Effects of Ligustrazine on Ischemia-Reperfusion and DPPH Free Radical-Induced Myocardial Injury in Isolated Rat Hearts

Abstract

Previous investigations have suggested that tumor necrosis factor-alpha (TNF-α) can contribute to myocardial damage during ischemia-reperfusion. In the present study, we examined whether the cardioprotective effects of ligustrazine are related to inhibition of TNF-α production in the rat models of ischemia-reperfusion and 1,1-diphenyl-2-picrylhydrazyl (DPPH) free radical-induced myocardial injury. Ischemia for 20 min and reperfusion for 40 min caused a decline in cardiac function (left ventricular pressure, ± dp/dt _max, heart rate and coronary flow) and an increase in the release of creatine kinase in coronary effluent and the content of TNF-α in myocardial tissues. Similarly, perfusion with DPPH (100 nM) for 30 min significantly decreased cardiac function, and increased the release of creatine kinase and the content of TNF-α. Ligustrazine at the concentration of 40 or 80 mg/L markedly improved cardiac function and reduced the release of creatine kinase and the content of TNF-α in myocardial tissues in hearts subjected to ischemia-reperfusion or DPPH perfusion. These results suggest that the cardioprotection afforded by ligustrazine is related to a reduction of TNF-α content by inhibition of free radical production in isolated rat hearts.

Ligustrazine - tumor necrosis factor-alpha - myocardial ischemia-reperfusion injury - 1,1-diphenyl-2-picrylhydrazyl - rat isolated heart - Ligusticum wallichii - Apiaceae

References

• 1 Marban E, Koretsune Y, Corretti M, Chacko V P, Kusuoke H. Calcium and its role in myocardial cell injury during ischemia reperfusion.  Circulation. 1989;  80 IV17-22
• 2 Goldhaber J I, Weiss J N. Oxygen free radicals and cardiac reperfusion abnormalities.  Hypertension. 1992;  20 118-27
• 3 Sack M. Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease.  Pharmacol Ther. 2002;  94 123-35
• 4 Gurevitch J, Frolkis I, Yuhas Y, Paz Y, Matsa M, Mohr R. et al . Tumor necrosis factor-alpha is released from the isolated heart undergoing ischemia reperfusion.  J Am Coll Cardiol. 1996;  28 247-52
• 5 Li Y J, Peng J. The cardioprotection of calcitonin gene-related peptide-mediated preconditioning.  Eur J Pharmacol. 2002;  442 173-7
• 6 Kwan C Y, Daniel E E, Chen M C. Inhibition of vasoconstriction by tetramethylpyrazine: does it act by blocking the voltage dependent Ca²⁺ channel?.  J Cardiovasc Pharmacol. 1990;  15 157-62
• 7 Jiang D J, Hu G Y, Jiang J L, Xiang H L, Deng H W, Li Y J. Relationship between protective effect of xanthone on endothelial cells and endogenous nitric oxide synthase inhibitors.  Bioorg Med Chem. 2003;  11 5171-7
• 8 Hu C P, Xiao L, Deng H W, Li Y J. The cardioprotection of rutaecarpine is mediated by endogenous calcitonin related-gene peptide through activation of vanilloid receptors in guinea-pig hearts.  Planta Med. 2002;  68 705-9
• 9 Ferrari R, Visioli O. Protective effects of calcium antagonists against ischaemia and reperfusion damage.  Drugs. 1991;  42 14-26
• 10 Chen J B, Huang C X, Tang Q J, Li J J, Xu J L, Li G S. Electrophysiological effect of tetramethylpyrazine on ventricular myocardium.  Acta Acad Med Hubei. 1999;  20 111-3
• 11 Jin Z Q, Chen X. A simple reproducible model of free radical-injury isolated heart induced by 1,1-diphenyl-2-picryl-hydrazyl (DPPH).  J Pharmacol Toxicol Method. 1998;  39 63-70
• 12 Frangogiannis N G, Lindsey M L, Michael L H, Youker K A, Bressler R B, Mendoza L H. et al . Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion.  Circulation. 1998;  98 699-710
• 13 Krown K A, Page M T, Nguyen C, Zechner D, Gutierrez V, Comstock K L. et al . Tumor necrosis factor-alpha induced apoptosis in cardiac myocytes: involvement of the sphingolipid signaling cascade in cardiac myocytes.  J Clin Invest. 1996;  98 2854-65